This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

F. H. BOONE, M.B.; A. A. WEECH, M.D.

Am J Dis Child. 1924;27(1):39-48.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The peculiar difficulties of administering any form of intravenous therapy to small infants are well known. The median longitudinal sinus has proved most valuable as a route for giving fluids intravenously, or for transfusion, but, occasionally, attempts to administer arsphenamin and neo-arsphenamin intrasinusly have been attended with fatal results. At times, the superficial veins of the scalp are prominent and may be utilized, but often the external jugulars are the only veins available, and at times even these are not visible. It is often difficult, except for those who have had much practice, to make a clean puncture into a jugular vein which is covered by skin, fascia, and platysma muscle. As a result, various attempts have been made to prepare arsenicals in a form suitable for subcutaneous, intramuscular and rectal administration. Neo-arsphenamin, specially neutralized for intramuscular injection, can now be obtained, but its use is attended by the frequent . . . [Full Text PDF of this Article]

Author Affiliations
TORONTO; BALTIMORE

From the Harriet Lane Home, Johns Hopkins Hospital, and the Department of Pediatrics, Johns Hopkins University.

Footnotes
Received for publication, Sept. 17, 1923.

This clinical trial of sulpharsphenamin was suggested by Dr. Carl Voegtlin of the United States Public Health Service, who furnished us with a supply of the drug for our studies.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?